Tenax Therapeutics Investor Relations Material

Tenax Therapeutics Inc is a U.S.-based pharmaceutical company engaged in the development of therapies for cardiovascular and pulmonary diseases. The company focuses on late-stage clinical development and regulatory advancement of drug candidates aimed at addressing unmet medical needs in rare conditions. It operates within the biotechnology sector and collaborates with research institutions and clinical networks. The company is headquartered in Chapel Hill, North Carolina, and its shares are listed on the NASDAQ.